Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 4,744	$ 6,009	$ 5,305
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for depreciation and net amortization	2,516	2,604	2,329
Provision (benefit) for deferred income taxes	(33)	400	(100)
Provision for loan losses	4,015	785	1,390
Deferred net loan origination costs	(514)	(443)	(292)
Proceeds from sales of loans held for sale	63,510	102,080	63,305
Originations of loans held for sale	(61,950)	(101,812)	(62,267)
Gain on sale of loans	(1,373)	(1,918)	(1,064)
Provision for (recapture of) mortgage servicing right valuation allowance	(259)	199	(122)
Net (gain) loss on sale of premises and equipment		3	(15)
Realized gain on sale of securities available for sale	(12)		(32)
Net loss on sale and provision for write-down of foreclosed assets	301	443	972
Increase in cash surrender value of life insurance	(402)	(407)	(415)
Gain on bargain purchase		(851)
Changes in operating assets and liabilities:
Accrued interest receivable	81	313	170
Other assets	1,590	386	64
Accrued expenses and other liabilities	820	(235)	429
Net cash provided by operating activities	13,034	7,556	9,657
Cash flows from investing activities:
Proceeds from maturities of securities available for sale	41,824	49,290	17,046
Proceeds from sale of securities available for sale	986		37
Proceeds from maturities of securities held to maturity	6,502	10,778	4,264
Payment for purchase of securities available for sale	(31,241)	(32,368)	(21,697)
Payment for purchase of securities held to maturity	(8,960)	(11,696)	(1,021)
Cash acquired on purchase of Marathon State Bank		14,910
Net redemption (net purchase) of bank certificates of deposit	2,229	(1,981)
Net redemption (purchase) of FHLB stock	(50)	744
Net increase in loans	(36,746)	(10,349)	(7,130)
Capital expenditures	(334)	(572)	(191)
Proceeds from sale of premises and equipment			15
Proceeds from sale of foreclosed assets	831	1,527	987
Purchase of bank-owned life insurance	(611)		(92)
Net cash provided by (used in) investing activities	(25,570)	20,283	(7,782)
Cash flows from financing activities:
Net increase (decrease) in non-interest-bearing deposits	12,825	(9,902)	17,366
Net decrease in interest-bearing deposits	(694)	(6,832)	(1,114)
Net decrease in Federal Home Loan Bank advances	(12,075)		(7,310)
Net increase (decrease) in other borrowings	(287)	1,037	(11,820)
Repayment of senior subordinated notes	(3,000)
Dividends declared	(1,289)	(1,247)	(1,168)
Proceeds from exercise of stock options		9	45
Purchase of treasury stock	(269)	(262)
Net cash used in financing activities	(4,789)	(17,197)	(4,001)
Net increase (decrease) in cash and cash equivalents	(17,325)	10,642	(2,126)
Cash and cash equivalents at beginning	48,847	38,205	40,331
Cash and cash equivalents at end	31,522	48,847	38,205
Cash paid during the period for:
Interest	5,645	7,177	8,982
Income taxes	759	2,146	2,445
Noncash investing and financing activities:
Loans charged off	4,743	1,332	1,587
Loans transferred to foreclosed assets	1,342	1,295	1,006
Loans originated on sale of foreclosed assets	234	490	1,075
Grants of unvested restricted stock at fair value	210	200	200
Vesting of restricted stock grants	165	116	84
Amortization of unrealized gain on securities held to maturity transferred from securities available for sale	$ 420	$ 452	$ 516